The Global Market for Synthetic Biology is Projected to Reach US$16.8 Billion by 2020
Expanding Application Areas to
Drive Growth in the Global Synthetic Biology Market, According to a New Report
by Global Industry
Analysts, Inc.
GIA announces the release of a comprehensive global
report on Synthetic Biology. The
global market for Synthetic Biology is projected to reach US$16.8 billion by 2020,
driven
by expanding commercial applications in end-use sectors such as energy,
medicine, environment, agriculture and chemicals.
Global interest in synthetic biology is driven by the technology’s
promised potential to change society by bringing about a fundamental shift in
the way energy, food and other industrial products are produced. In the field
of healthcare, synthetic biology flaunts the potential to radically alter the
way in which diseases are detected, prevented and cured. Synthetic biology is
defined as engineered biology focused on the development of artificial,
biologically inspired systems. In medical science, synthetic biology refers to the
design and development of new biological organisms based on artificially created
DNAs to design and develop new organisms or biochemical systems. This
revolutionary branch of science brings together multiple disciplines such as
computer modeling, engineering and biological sciences for creating
next-generation biological systems, parts and devices.
Rapid advancements in DNA sequencing and synthesis led
by plummeting cost of DNA sequencing is a major factor fostering growth in the
market. Computational modeling, DNA synthesis, and DNA sequencing, represent
few of the major technologies that are playing key roles in pushing the
evolution of synthetic biology into the level. Commercial gene synthesis tools
and pre-designed synbio tools are finding acceptance among molecular cloners.
Synthetic biology based food ingredients are witnessing rapid commercialization
supported by the shifting focus on synbio ingredients in the global food supply
chain.
Several of the leading chemical, energy,
pharmaceutical, food, forestry and agribusiness companies are investing in
synthetic biology research to develop new and potent products. Energy &
Chemicals represents the largest as well as the fastest growing end-use market.
Synthetic biology is opening new avenues for the scientific community to
convert low-cost feedstock such as amino acids and sugars into fuels and
medicines. The success of Genetically Modified (GM) seeds has opened up
numerous opportunities for synthetic biology, with leading players in the
sector investing substantial resources in developing a range of crops featuring
enhanced nutritional value and pest protection. Additional
applications in the area of agriculture include the development of new eco-friendly
pesticides.
As
stated by the new market research report on, Synthetic Biology, Europe
represents the largest market worldwide, supported by high R&D interest in
developing synthetic biology based products. Within Europe, Germany and the UK remain
prominent markets. Asia-Pacific is forecast to emerge as the fastest-growing
market with a projected CAGR of 41.9% over the analysis period.
Major players covered in the report include Agilent
Technologies Inc., Amyris Inc., BP PLC, Chromatin Inc., Gevo Inc., 454 Life
Sciences, Epoch Life Science Inc., Evolva SA, Solazyme Inc., Synthetic Genomics
Inc., Synthetic Biologics Inc., DNA2.0, and Intrexon Corp, among others.
Comments
Post a Comment